Last reviewed · How we verify

NCT06025058

Neopep-S-based EasyDew MD Regen Cream for Radiotherapy Subject After Breast Tumor Resection

Completed NA Last updated 6 September 2023
What this trial tests

NA trial testing Easy Dew MD Regen Cream in Skin Lesion in 30 participants. Completed in 28 July 2023.

Timeline
11 November 2022
Primary endpoint
27 July 2023
28 July 2023

Quick facts

Lead sponsorEun-ji Kim
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment30
Start date11 November 2022
Primary completion27 July 2023
Estimated completion28 July 2023
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Eun-ji Kim

Who can join

19 and older, any sex, with Skin Lesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical study is conducted prospectively for 3 months after medical device treatment. It is a comparative clinical study of the leading control group.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical Measurement of Transepidermal Water Loss.
    Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148

Verify or expand the search:

Other trials of Easy Dew MD Regen Cream

Trials testing the same drug.

Other recruiting trials for Skin Lesion

Currently open trials in the same condition.

Other Eun-ji Kim trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06025058.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing